{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:06:44Z","timestamp":1740107204647,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00405-023-08330-0","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T06:01:41Z","timestamp":1700719301000},"page":"1425-1434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiation-induced nasopharyngeal ulcers after re-irradiation with intensity-modulated radiotherapy in locoregional recurrent nasopharyngeal carcinoma patients: a dose\u2013volume\u2013outcome analysis"],"prefix":"10.1007","volume":"281","author":[{"given":"Meng-Shan","family":"Ni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-Fang","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-Sen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Run","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Ping","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Su","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6302-9690","authenticated-orcid":false,"given":"Hong-Mei","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"8330_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87\u2013108. https:\/\/doi.org\/10.3322\/caac.21262","journal-title":"CA Cancer J Clin"},{"key":"8330_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.radonc.2014.02.003","volume":"110","author":"AWM Lee","year":"2014","unstructured":"Lee AWM, Ng WT, Chan LLK, Hung WM, Chan CCC, Sze HCK et al (2014) Evolution of treatment for nasopharyngeal cancer\u2013success and setback in the intensity-modulated radiotherapy era. Radiother Oncol 110:377\u2013384","journal-title":"Radiother Oncol"},{"key":"8330_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1748-717X-9-60","volume":"9","author":"F Kong","year":"2014","unstructured":"Kong F, Ying H, Du C, Huang S, Zhou J, Chen J et al (2014) Patterns of local-regional failure after primary intensity modulated radiotherapy for nasopharyngeal carcinoma. Radiat Oncol 9:60","journal-title":"Radiat Oncol"},{"key":"8330_CR4","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.ijrobp.2009.11.024","volume":"79","author":"WT Ng","year":"2011","unstructured":"Ng WT, Lee MCH, Hung WM, Choi CW, Lee KC, Chan OSH et al (2011) Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 79:420\u2013428","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"8330_CR5","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1200\/JCO.2008.19.9109","volume":"27","author":"N Lee","year":"2009","unstructured":"Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P et al (2009) Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol 27:3684\u20133690","journal-title":"J Clin Oncol"},{"key":"8330_CR6","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.7150\/jca.20351","volume":"8","author":"S-B Liang","year":"2017","unstructured":"Liang S-B, Wang Y, Hu X-F, He S-S, Yang X-L, Liu L-Z et al (2017) Survival and Toxicities of IMRT Based on the RTOG Protocols in Patients with Nasopharyngeal Carcinoma from the Endemic Regions of China. J Cancer 8:3718\u20133724","journal-title":"J Cancer"},{"key":"8330_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/hed.24645","volume":"39","author":"OSH Chan","year":"2017","unstructured":"Chan OSH, Sze HCK, Lee MCH, Chan LLK, Chang ATY, Lee SWM et al (2017) Reirradiation with intensity-modulated radiotherapy for locally recurrent T3\u2013T4 nasopharyngeal carcinoma. Head Neck 39:533\u2013540","journal-title":"Head Neck"},{"key":"8330_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/hed.20161","volume":"27","author":"KH Yu","year":"2005","unstructured":"Yu KH, Leung SF, Tung SY, Zee B, Chua DTT, Sze WM et al (2005) Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Head Neck 27:397\u2013405","journal-title":"Head Neck"},{"key":"8330_CR9","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.oraloncology.2012.02.017","volume":"48","author":"AWM Lee","year":"2012","unstructured":"Lee AWM, Fee WE, Ng WT, Chan LK (2012) Nasopharyngeal carcinoma: salvage of local recurrence. Oral Oncol 48:768\u2013774","journal-title":"Oral Oncol"},{"key":"8330_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.oraloncology.2018.06.017","volume":"84","author":"Y Li","year":"2018","unstructured":"Li Y, Xu T, Qian W, Lu X, Hu C (2018) Radiation-induced nasopharyngeal ulcers after intensity modulated radiotherapy in primary nasopharyngeal carcinoma patients: a dose-volume-outcome analysis. Oral Oncol 84:1\u20136","journal-title":"Oral Oncol"},{"key":"8330_CR11","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1186\/s12885-018-5055-5","volume":"18","author":"F Kong","year":"2018","unstructured":"Kong F, Zhou J, Du C, He X, Kong L, Hu C et al (2018) Long-term survival and late complications of intensity-modulated radio therapy for recurrent nasopharyngeal carcinoma. BMC Cancer 18:1139","journal-title":"BMC Cancer"},{"key":"8330_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1748-717X-6-22","volume":"6","author":"F Roeder","year":"2011","unstructured":"Roeder F, Zwicker F, Saleh-Ebrahimi L, Timke C, Thieke C, Bischof M et al (2011) Intensity modulated or fractionated stereotactic reirradiation in pati ents with recurrent nasopharyngeal cancer. Radiat Oncol 6:22","journal-title":"Radiat Oncol"},{"key":"8330_CR13","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ijrobp.2011.07.006","volume":"83","author":"S Qiu","year":"2012","unstructured":"Qiu S, Lin S, Tham IWK, Pan J, Lu J, Lu JJ (2012) Intensity-modulated radiation therapy in the salvage of locally recurr ent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 83:676\u2013683","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"8330_CR14","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/cam4.5020","volume":"12","author":"X-T Xiao","year":"2023","unstructured":"Xiao X-T, Wu Y-S, Chen Y-P, Liu X, Guo R, Tang L-L et al (2023) Patterns and prognosis of regional recurrence in nasopharyngeal carcin oma after intensity-modulated radiotherapy. Cancer Med 12:1399\u20131408","journal-title":"Cancer Med"},{"key":"8330_CR15","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/S0360-3016(02)02760-8","volume":"53","author":"C-Y Hsiung","year":"2002","unstructured":"Hsiung C-Y, Yorke ED, Chui C-S, Hunt MA, Ling CC, Huang E-Y et al (2002) Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharynge al carcinoma. Int J Radiat Oncol Biol Phys 53:638\u2013647","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"8330_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13014-022-01980-0","volume":"17","author":"Y Xu","year":"2022","unstructured":"Xu Y, Liu Y, Wang Z, Wang J, Zhang J, Chen X et al (2022) Irradiation-induced nasopharyngeal necrosis (INN) in newly diagnosed nasopharyngeal carcinoma treated by intensity-modulated radiation therapy: clinical characteristics and the influence of treatment strategies. Radiat Oncol 17:13","journal-title":"Radiat Oncol"},{"key":"8330_CR17","doi-asserted-by":"publisher","first-page":"6253","DOI":"10.2147\/CMAR.S197841","volume":"11","author":"X-Y Li","year":"2019","unstructured":"Li X-Y, Sun X-S, Liu S-L, Chen Q-Y, Guo S-S, Liu L-T et al (2019) The development of a nomogram to predict post-radiation necro sis in nasopharyngeal carcinoma patients: a large-scale cohort study. CMAR 11:6253\u20136263. https:\/\/doi.org\/10.2147\/CMAR.S197841","journal-title":"CMAR"},{"key":"8330_CR18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.clon.2011.11.010","volume":"24","author":"F Han","year":"2012","unstructured":"Han F, Zhao C, Huang S-M, Lu L-X, Huang Y, Deng X-W et al (2012) Long-term outcomes and prognostic factors of re-irradiation for locall y recurrent nasopharyngeal carcinoma using intensity-modulated radioth erapy. Clin Oncol (R Coll Radiol) 24:569\u2013576","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"8330_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40880-016-0124-0","volume":"35","author":"Y-H Yu","year":"2016","unstructured":"Yu Y-H, Xia W-X, Shi J-L, Ma W-J, Li Y, Ye Y-F et al (2016) A model to predict the risk of lethal nasopharyngeal necrosis after re -irradiation with intensity-modulated radiotherapy in nasopharyngeal c arcinoma patients. Chin J Cancer 35:59","journal-title":"Chin J Cancer"},{"key":"8330_CR20","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1016\/j.ejca.2012.06.016","volume":"48","author":"Y-J Hua","year":"2012","unstructured":"Hua Y-J, Han F, Lu L-X, Mai H-Q, Guo X, Hong M-H et al (2012) Long-term treatment outcome of recurrent nasopharyngeal carcinoma trea ted with salvage intensity modulated radiotherapy. Eur J Cancer (Oxf Engl 1990) 48:3422\u20138. https:\/\/doi.org\/10.1016\/j.ejca.2012.06.016","journal-title":"Eur J Cancer (Oxf Engl 1990)"},{"key":"8330_CR21","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1097\/01.mlg.0000230435.71328.b9","volume":"116","author":"X-M Huang","year":"2006","unstructured":"Huang X-M, Zheng Y-Q, Zhang X-M, Mai H-Q, Zeng L, Liu X et al (2006) Diagnosis and management of skull base osteoradionecrosis after radiot herapy for nasopharyngeal carcinoma. Laryngoscope 116:1626\u20131631","journal-title":"Laryngoscope"},{"key":"8330_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.5732\/cjc.012.10252","volume":"32","author":"M-Y Chen","year":"2013","unstructured":"Chen M-Y, Mai H-Q, Sun R, Guo X, Zhao C, Hong M-H et al (2013) Clinical findings and imaging features of 67 nasopharyngeal carcinoma patients with postradiation nasopharyngeal necrosis. Chin J Cancer 32:533\u2013538","journal-title":"Chin J Cancer"},{"key":"8330_CR23","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3969\/j.issn.1674-5671.2011.04.08","volume":"3","author":"B Yang","year":"2011","unstructured":"Yang B, Chen Y, Xu L, Yao Y, Wu J (2011) Values of diffusion-weighted imaging in differential diagnosing necrosis and recurrence of nasopharyngeal carcinoma after radiotherapy. Chin J Oncol Prev Treat 3:298\u2013302. https:\/\/doi.org\/10.3969\/j.issn.1674-5671.2011.04.08","journal-title":"Chin J Oncol Prev Treat"},{"key":"8330_CR24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3760\/cma.j.issn.1004-4221.2016.05.004","volume":"25","author":"Z Yin","year":"2016","unstructured":"Yin Z, Gao L, Luo J, Yi J, Huang X, Wang K et al (2016) An analysis of clinical and dosimetric factors for postradiation nasopharyngeal necrosis in intensity-modulated radiotherapy for nasopharyngeal carcinoma. Chin J Radiat Oncol 25:438\u201342. https:\/\/doi.org\/10.3760\/cma.j.issn.1004-4221.2016.05.004","journal-title":"Chin J Radiat Oncol"},{"key":"8330_CR25","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/hed.21036","volume":"31","author":"YJ Hua","year":"2009","unstructured":"Hua YJ, Chen MY, Qian CN, Hong MH, Zhao C, Guo L et al (2009) Postradiation nasopharyngeal necrosis in the patients with nasopharyngeal carcinoma. Head Neck 31:807\u2013812","journal-title":"Head Neck"},{"key":"8330_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102428","volume":"109","author":"DR Adkins","year":"2022","unstructured":"Adkins DR, Haddad RI (2022) Clinical trial data of Anti-PD-1\/PD-L1 therapy for recurrent or metastatic nasopharyngeal Carcinoma: a review. Cancer Treat Rev 109:102428","journal-title":"Cancer Treat Rev"},{"key":"8330_CR27","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1002\/ijc.32869","volume":"146","author":"L Masterson","year":"2020","unstructured":"Masterson L, Howard J, Gonzalez-Cruz J, Jackson C, Barnett C, Overton L et al (2020) Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: beyond an era of chemoradiation? Int J Cancer 146:2305\u20132314","journal-title":"Int J Cancer"},{"key":"8330_CR28","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1200\/JCO.22.02328","volume":"41","author":"E Yilmaz","year":"2023","unstructured":"Yilmaz E, Ismaila N, Bauman JE, Dabney R, Gan G, Jordan R et al (2023) Immunotherapy and biomarker testing in recurrent and metastatic head and neck cancers: ASCO guideline. J Clin Oncol 41:1132\u20131146","journal-title":"J Clin Oncol"},{"key":"8330_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.762663","volume":"12","author":"X Zhou","year":"2021","unstructured":"Zhou X, Niu X, Liu P, Ou D, Zhu Y, Wang X (2021) Is immune therapy plus chemotherapy more effective than immune therapy alone for unresectable recurrent nasopharyngeal carcinoma? Front Immunol 12:762663","journal-title":"Front Immunol"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-023-08330-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-023-08330-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-023-08330-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T09:06:45Z","timestamp":1707469605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-023-08330-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["8330"],"URL":"https:\/\/doi.org\/10.1007\/s00405-023-08330-0","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"type":"print","value":"0937-4477"},{"type":"electronic","value":"1434-4726"}],"subject":[],"published":{"date-parts":[[2023,11,23]]},"assertion":[{"value":"5 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no competing interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study was approved by the Institutional Review Board of Fudan University Shanghai Cancer Center (Approval number 2009224\u20131).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}